K-numberK243133
Device nameNitrile Powder Free Examination Gloves with Low Dermatitis Potential, Tested for Use with Chemotherapy Drugs, Fentanyl Citrate and Gastric Acid
ApplicantKl-Kepong Rubber Products Sdn. Bhd.
Product codeLZA
Device classClass I
Decision dateJun 17, 2025
DecisionSubstantially Equivalent
Regulation880.6250
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

This is a single-use, disposable nitrile powder-free examination glove intended for medical purposes to prevent contamination between patient and examiner. The gloves feature low dermatitis potential and have been tested for resistance to chemotherapy drugs (54 drugs tested), fentanyl citrate, and gastric acid. The gloves are offered in six sizes (XS through XXL) in a non-sterile state.

Technological characteristics

The subject device is made of nitrile rubber, powder-free, ambidextrous with a beaded cuff, and features a treated inner surface for smooth donning without lubricant. The predicate device (K231938) has identical material, powder-free status, single-use design, and non-sterile state. The subject device adds an additional size (XXL) and differs in color (blue-green vs. grey). Both meet ASTM D6319 for physical properties, ASTM D5151 for freedom from holes, and ASTM D6124 for residual powder.

Test standards cited

ASTM D5151-19 (freedom from holes), ASTM D6319-19 (physical properties and dimensions), ASTM D6124-06 (residual powder), ASTM D6978-05 (chemotherapy drug permeation resistance), ISO 10993-10:2021 (skin sensitization), ISO 10993-11:2017 (systemic toxicity), and ISO 10993-23:2021 (irritation). Clinical testing used the Modified Draize-95 Test for skin sensitization.

Substantial equivalence argument

The subject device is substantially equivalent because it has identical device classification, product codes, materials, intended use, and regulatory requirements as the predicate. Both passed equivalent biocompatibility and safety testing (skin sensitization, systemic toxicity, and irritation). The permeation testing against 54 chemotherapy drugs, fentanyl citrate, and gastric acid demonstrates comparable or superior chemical resistance; where the predicate tested 52 drugs, the subject tested all 52 plus 2 additional drugs. The only material differences (color and addition of XXL size) do not affect safety or effectiveness.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →